| Dr Katrinne Anne Diaz Mariano, PHARMD | |
|
9305 Mission Gorge Rd, Santee, CA 92071-3815 | |
| (619) 258-8011 | |
| (209) 341-0849 |
| Full Name | Dr Katrinne Anne Diaz Mariano |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9305 Mission Gorge Rd, Santee, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356850952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 062186 (New York) | Secondary |
| 183500000X | Pharmacist | 75668 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katrinne Anne Diaz Mariano, PHARMD 9305 Mission Gorge Rd, Santee, CA 92071-3815 Ph: (619) 258-8011 | Dr Katrinne Anne Diaz Mariano, PHARMD 9305 Mission Gorge Rd, Santee, CA 92071-3815 Ph: (619) 258-8011 |
News Archive
Cardiovascular Systems, Inc., announces the first patient enrollment in its ORBIT II Investigational Device Exemption (IDE) clinical trial to evaluate the safety and effectiveness of its Diamondback 360® System in treating coronary arteries. The patient was treated by Dr. P.K. Khanna, an interventional cardiologist with Eisenhower Medical Center in Palm Springs, Calif. Dr. Khanna also treated patients in the 2008 ORBIT I coronary study of 50 patients in India.
Chronic myeloid leukaemia patients with rare BCR-ABL fusions may be missed by quantitative polymerase chain reaction, research suggests.
In a study that included data from more than 1.5 million patients, use of vascular closure devices and the anticoagulant bivalirudin were associated with significantly lower bleeding rates for patients following a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a study in the June 2 issue of JAMA. The researchers also found that patients who may benefit most from these treatments, those at greatest risk of bleeding, were least likely to receive them.
Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.
› Verified 9 days ago
Mazin J Hami, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9759 Mission Gorge Rd, Santee, CA 92071 Phone: 619-449-1950 Fax: 619-449-4446 | |
Desire Annamarie Hamler, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9730 Mission Gorge Rd, Santee, CA 92071 Phone: 619-448-5110 | |
Dina Jamil, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9836 Magnolia Ave., Santee, CA 92071 Phone: 619-777-1000 Fax: 619-334-0049 | |
Kaheun Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9730 Mission Gorge Rd, Santee, CA 92071 Phone: 619-448-5110 | |
Matthew Van Noort, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10512 Mission Gorge Rd, Santee, CA 92071 Phone: 619-258-7942 | |
Ms. Ann Gaggi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 Park Center Dr, Santee, CA 92071 Phone: 619-596-6342 | |
Dr. Byron E Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9846 Mission Gorge Rd, Target Pharmacy Store T1485, Santee, CA 92071 Phone: 619-449-9682 Fax: 619-449-9682 |